340 related articles for article (PubMed ID: 9164182)
1. Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma.
Altehoefer C; Blum U; Bathmann J; Wüstenberg C; Uhrmeister P; Laubenberger J; Lange W; Schwarzkopf J; Moser E; Langer M
J Clin Oncol; 1997 May; 15(5):1754-60. PubMed ID: 9164182
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomas.
Krause T; Eisenmann N; Reinhardt M; Bathmann J; Altehoefer C; Finke J; Moser E
Ann Oncol; 1999 Jan; 10(1):79-85. PubMed ID: 10076726
[TBL] [Abstract][Full Text] [Related]
3. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
Moog F; Bangerter M; Kotzerke J; Guhlmann A; Frickhofen N; Reske SN
J Clin Oncol; 1998 Feb; 16(2):603-9. PubMed ID: 9469348
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of pelvic and femoral bones for detection of bone marrow infiltration in patients with non-Hodgkins lymphoma.
Al-Mulhim FA
Saudi Med J; 2005 Jan; 26(1):31-6. PubMed ID: 15756349
[TBL] [Abstract][Full Text] [Related]
5. Malignant lymphoma: bone marrow imaging versus biopsy.
Linden A; Zankovich R; Theissen P; Diehl V; Schicha H
Radiology; 1989 Nov; 173(2):335-9. PubMed ID: 2678249
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
Pelosi E; Penna D; Douroukas A; Bellò M; Amati A; Arena V; Passera R; Bisi G
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):469-75. PubMed ID: 21150862
[TBL] [Abstract][Full Text] [Related]
7. Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma?
Fuster D; Chiang S; Andreadis C; Guan L; Zhuang H; Schuster S; Alavi A
Nucl Med Commun; 2006 Jan; 27(1):11-5. PubMed ID: 16340718
[TBL] [Abstract][Full Text] [Related]
8. [Bone marrow scintigraphy and magnetic resonance tomography in malignant lymphomas: comparison with histologic results].
Linden A; Zankovich R; Theissen P; Schauerte G; Diehl V; Schicha H
Nuklearmedizin; 1989 Oct; 28(5):166-71. PubMed ID: 2813080
[TBL] [Abstract][Full Text] [Related]
9. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
[TBL] [Abstract][Full Text] [Related]
10. Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma.
Xiao-Xue W; Xinyue H; Lijun Z
Med Clin (Barc); 2020 Jan; 154(2):61-65. PubMed ID: 31757394
[TBL] [Abstract][Full Text] [Related]
11. Detection of bone marrow infiltration by non-Hodgkin's lymphoma--comparison of histological findings, analysis of gene rearrangements, and examination by magnetic resonance imaging.
Knauf WU; Gückel F; Döhner H; Semmler W; Trümper L; Ho AD
Klin Wochenschr; 1991 May; 69(8):345-50. PubMed ID: 1653380
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
[TBL] [Abstract][Full Text] [Related]
13. [NMR tomographic imaging of bone marrow infiltrates in malignant lymphoma].
Gückel F; Semmler W; Döhner H; Knauf W; Görich J; Ho AD; van Kaick G
Rofo; 1989 Jan; 150(1):26-31. PubMed ID: 2536492
[TBL] [Abstract][Full Text] [Related]
14. The relation of bone marrow scintigraphy and unilateral bone marrow biopsy in malignant lymphoma.
Esmaili J; Safaee SR; Sharifian R; Shoeybi S; Gholamrezanezhad A
Hell J Nucl Med; 2005; 8(2):125-8. PubMed ID: 16142255
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
Ribrag V; Vanel D; Leboulleux S; Lumbroso J; Couanet D; Bonniaud G; Aupérin A; Masson F; Bosq J; Edeline V; Fermé C; Pigneur F; Schlumberger M
Eur J Radiol; 2008 May; 66(2):325-31. PubMed ID: 17651934
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of bone marrow in lymphoproliferative disorders: correlation with bone marrow biopsy.
Döhner H; Gückel F; Knauf W; Semmler W; van Kaick G; Ho AD; Hunstein W
Br J Haematol; 1989 Sep; 73(1):12-7. PubMed ID: 2679859
[TBL] [Abstract][Full Text] [Related]
17. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging.
Hoane BR; Shields AF; Porter BA; Shulman HM
Blood; 1991 Aug; 78(3):728-38. PubMed ID: 1859885
[TBL] [Abstract][Full Text] [Related]
18. Marrow space imaging in Hodgkin's disease. MRI prior to biopsy for improved accuracy.
Barbu RR; Port JL; Elkowitz SS; Leonidas JC
Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):343-5. PubMed ID: 8328651
[TBL] [Abstract][Full Text] [Related]
19. [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow].
Reske SN; Karstens JH; Glöckner WM; Ammon J; Büll U
Rofo; 1990 Jan; 152(1):60-6. PubMed ID: 2154012
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging of bone marrow versus bone marrow biopsy in malignant lymphoma.
Ozgüroglu M; Esen Ersavasti G; Demir G; Aki H; Demirelli F; Kanberoglu K; Mandel N; Büyükünal E; Serdengeçti S; Berkarda B
Pathol Oncol Res; 1999; 5(2):123-8. PubMed ID: 10393364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
